Duality Advisers’s Allergan plc AGN Stock Holding History

Duality Advisers’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-74,320	Closed	-$10.9M	–	297
2019 Q1	$10.9M	Sell	74,320 -25,050	-25%	-$3.63M	0.64%	34
2018 Q4	$13.3M	Buy	+99,370	New	+$16.3M	0.77%	25

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Duality Advisers's AGN Position: Q2 2019 in Review

Duality Advisers sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 74,320 shares — an estimated $10.9M sold.

Duality Advisers first reported a position in AGN in Q4 2018 and held it in 2 quarters. The position peaked at $13.3M in Q4 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Duality Advisers reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Duality Advisers sold 74,320 Allergan plc shares in Q2 2019, an estimated $10.9M.
Duality Advisers first reported a position in Allergan plc in Q4 2018 and held it in 2 quarters.
Duality Advisers's Allergan plc position peaked at $13.3M in Q4 2018.
970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Duality Advisers's 13F filing for Q2 2019, filed 12 Aug 2019.